Propofol for Treatment-Resistant Depression: A Pilot Study

BACKGROUND: We hypothesized that propofol, a unique general anesthetic that engages N-methyl-D-aspartate and gamma-aminobutyric acid receptors, has antidepressant properties. This open-label trial was designed to collect preliminary data regarding the feasibility, tolerability, and efficacy of deep...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Neuropsychopharmacol
Главные авторы: Mickey, Brian J, White, Andrea T, Arp, Anna M, Leonardi, Kolby, Torres, Marina M, Larson, Adam L, Odell, David H, Whittingham, Sara A, Beck, Michael M, Jessop, Jacob E, Sakata, Derek J, Bushnell, Lowry A, Pierson, Matthew D, Solzbacher, Daniela, Kendrick, E Jeremy, Weeks, Howard R, Light, Alan R, Light, Kathleen C, Tadler, Scott C
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Regular Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276046/
https://ncbi.nlm.nih.gov/pubmed/30260415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyy085
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы